CanFite Biopharma (CANF)
(Delayed Data from AMEX)
$2.09 USD
-0.05 (-2.42%)
Updated May 10, 2024 03:58 PM ET
3-Hold of 5 3
B Value F Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 6/6/24 |
---|---|
Current Quarter | NA |
EPS Last Quarter | -0.31 |
Last EPS Surprise | -14.81% |
ABR | 1.00 |
Earnings ESP
|
NA |
---|---|
Current Year | -0.03 |
Next Year | NA |
EPS (TTM) | -1.79 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 10.00M | NA |
# of Estimates | NA | NA | 1 | NA |
High Estimate | NA | NA | 10.00M | NA |
Low Estimate | NA | NA | 10.00M | NA |
Year ago Sales | 0.20M | 0.20M | 0.74M | 10.00M |
Year over Year Growth Est. | NA | NA | 1,245.91% | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | -0.03 | NA |
# of Estimates | NA | NA | 1 | NA |
Most Recent Consensus | NA | NA | -0.03 | NA |
High Estimate | NA | NA | -0.03 | NA |
Low Estimate | NA | NA | -0.03 | NA |
Year ago EPS | -0.65 | -0.40 | -1.79 | -0.03 |
Year over Year Growth Est. | NA | NA | 98.32% | NA |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | NA | NA | 0 | NA |
Up Last 30 Days | NA | NA | 0 | NA |
Up Last 60 Days | NA | NA | 0 | NA |
Down Last 7 Days | NA | NA | 0 | NA |
Down Last 30 Days | NA | NA | 0 | NA |
Down Last 60 Days | NA | NA | 0 | NA |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | NA | NA | -0.03 | NA |
7 Days Ago | NA | NA | -0.03 | NA |
30 Days Ago | NA | NA | -0.03 | NA |
60 Days Ago | NA | NA | -0.27 | -0.27 |
90 Days Ago | NA | NA | -0.27 | -0.27 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | NA | NA | -0.03 | NA |
Zacks Consensus Estimate | NA | NA | -0.03 | NA |
Earnings ESP | NA | NA | 0.00% | NA |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.31 | -0.43 | -0.40 | -0.65 | NA |
Estimate | -0.27 | -0.43 | -0.54 | NA | NA |
Difference | -0.04 | 0.00 | 0.14 | NA | 0.03 |
Surprise | -14.81% | 0.00% | 25.93% | NA | 3.71% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more